Anastomosis Complications After Bronchoplasty: Incidence, Risk Factors, and Treatment Options Reported by a Referral Cancer Center
Overview
Authors
Affiliations
Background: Sleeve lobectomy with bronchoplasty is a safe surgical technique for the management of lung cancer and endobronchial localization of extrapulmonary cancers. However, anastomotic complications can occur, and treatment strategies are not standardized.
Methods: Data from 280 patients subjected to bronchoplasty were retrospectively analyzed, focusing on surgical techniques, anastomotic complications, and their management. Multivariate analysis was performed, and Kaplan-Meier curves were used to determine survival.
Results: Ninety percent of 280 surgeries were for lung cancer. Anastomotic complications occurred in 6.42% of patients: late stenosis in 3.92% and broncho-pleural fistula in 1.78%. The median survival was 65.90 months (95% CI = 41.76-90.97), with no difference ( = 0.375) for patients with (51.28 months) or without (71.03 months) anastomotic complications. Mortality at 30 days was higher with anastomotic complications (16.7% vs. 3%, = 0.014). Multivariable analysis confirmed pathological stage (N+) as a risk factor for anastomotic complications ( = 0.016). Our mortality (3.93%) and morbidity rate (41.78%) corresponded to recent series results.
Conclusions: In our experience, surgery is preferred to avoid life-threatening complications in bronchopleural fistulas. Bronchoscopic balloon dilatation is preferred for benign strictures. The nodal stage is related to complications ( = 0.0014), reflecting the aggressiveness of surgery, which requires extended radical lymphadenectomy.